When to resume Enbrel (etanercept) for rheumatoid arthritis (RA) following a cephalomedullary nail (CMN) for an intertrochanteric hip fracture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Resuming Enbrel (Etanercept) After Cephalomedullary Nail for Intertrochanteric Hip Fracture

Etanercept should be restarted once the surgical wound shows evidence of healing, all sutures/staples are out, there is no significant swelling, erythema, or drainage, and there is no clinical evidence of non-surgical site infections, which typically occurs around 14 days after surgery. 1

Rationale for Timing of Biologic Restart

The decision to restart biologic therapy like Enbrel (etanercept) after orthopedic surgery should be based on careful evaluation of:

  • Wound healing status - evidence of proper healing 1
  • Absence of sutures/staples 1
  • Resolution of significant swelling, erythema, or drainage 1
  • No clinical evidence of surgical or non-surgical site infections 1

This typically corresponds to approximately 14 days post-surgery, which is when wound closure is generally achieved following procedures like cephalomedullary nailing for intertrochanteric hip fractures 1.

Clinical Considerations

Factors That May Influence Timing

  • History of prior severe infections may warrant longer withholding periods 1
  • History of prosthetic joint infections may require extended medication withholding 1
  • Wound healing complications would necessitate delaying restart of etanercept 1

Potential Complications of Delayed Restart

  • Disease flares may occur if biologic therapy is withheld for extended periods 1
  • In a Medicare dataset study, patients who restarted infliximab (another biologic) within 4 weeks after surgery had better outcomes than those who restarted later 1

Glucocorticoid Management

If the patient is also on glucocorticoids for rheumatoid arthritis:

  • Continue the current daily dose of glucocorticoids rather than administering supraphysiologic "stress doses" 1
  • This recommendation applies to patients receiving ≤16 mg/day prednisone or equivalent 1
  • Higher glucocorticoid exposure is associated with increased risk of complications, including hyperglycemia 1

Common Pitfalls to Avoid

  • Restarting biologics too early (before wound healing) may increase infection risk 1
  • Delaying restart unnecessarily may lead to disease flares and worse outcomes 1
  • Failure to monitor for signs of infection before restarting therapy 1
  • Administering unnecessary supraphysiologic glucocorticoid doses perioperatively 1

Special Considerations for Cephalomedullary Nail Procedures

While the guidelines primarily address total hip and knee arthroplasty, the same principles apply to cephalomedullary nail procedures for intertrochanteric fractures:

  • Cephalomedullary nailing is associated with minimal blood loss and lower infection rates compared to other techniques 2
  • Patients with rheumatoid arthritis may have higher rates of complications after intertrochanteric fracture fixation, including avascular necrosis and nonunion 3
  • Complete healing of intertrochanteric fractures with cephalomedullary nails typically occurs around 13.5 weeks 4

By following these evidence-based recommendations, you can optimize both fracture healing and rheumatoid arthritis management while minimizing infection risk and other complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intertrochanteric fractures of the femur in rheumatoid arthritis patients.

Clinical orthopaedics and related research, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.